Literature DB >> 8893278

Lectin-bearing polymerized liposomes as potential oral vaccine carriers.

H Chen1, V Torchilin, R Langer.   

Abstract

PURPOSE: The potential of using lectin-modified polymerized liposomes as Peyer's patch targeted oral delivery vehicles was examined.
METHODS: Two types of lectins, Ulex Europaeus Agglutinin I (UEA I) and Wheat Germ Agglutinin (WGA), were modified with a hydrophobic anchor N-glutaryl-phosphotidylethanolamine (NGPE). The modified lectins were incorporated into liposome bilayers and the liposomes were subsequently stabilized through polymerization. The presence of the lectins on the liposome surfaces was first confirmed with X-ray photoelectron spectroscopy. Surface-immobilized lectins were then shown to retain their carbohydrate binding activities as well as specificities based on an in vitro aggregation assay. Finally, delivery efficiencies of lectin-bearing liposomes were determined in mice.
RESULTS: About 10.5% UEA I liposomes and 5.8% WGA liposomes were taken up from the gastrointestinal tract. These numbers are significantly higher than the 3.2% observed in the case of lectin-free liposomes. At the same time, UEA I liposomes exhibited the most effective Peyer's patch targeting among the three, which directly correlated with the highest delivery efficiency observed.
CONCLUSIONS: This establishes that lectin modification of liposomes can promote binding to Peyer's patches, which will give improved efficiency for Peyer's patch targeted delivery. All these point to the potential for these lectin-modified liposomes as novel vehicles for oral vaccination.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893278     DOI: 10.1023/a:1016030202104

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Differential surface characteristics of M cells from mouse intestinal Peyer's and caecal patches.

Authors:  M A Clark; M A Jepson; N L Simmons; B H Hirst
Journal:  Histochem J       Date:  1994-03

2.  A new hydrophobic anchor for the attachment of proteins to liposomal membranes.

Authors:  V Weissig; J Lasch; A L Klibanov; V P Torchilin
Journal:  FEBS Lett       Date:  1986-06-23       Impact factor: 4.124

3.  The measurement of amino groups in proteins and peptides.

Authors:  R Fields
Journal:  Biochem J       Date:  1971-09       Impact factor: 3.857

4.  Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch.

Authors:  M R Neutra; T L Phillips; E L Mayer; D J Fishkind
Journal:  Cell Tissue Res       Date:  1987-03       Impact factor: 5.249

Review 5.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

6.  Can intact liposomes be absorbed in the gut?

Authors:  D S Deshmukh; W D Bear; H Brockerhoff
Journal:  Life Sci       Date:  1981-01-19       Impact factor: 5.037

7.  In vitro evaluation of polymerized liposomes as an oral drug delivery system.

Authors:  J Okada; S Cohen; R Langer
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

8.  Differential expression of lectin-binding sites defines mouse intestinal M-cells.

Authors:  M A Clark; M A Jepson; N L Simmons; T A Booth; B H Hirst
Journal:  J Histochem Cytochem       Date:  1993-11       Impact factor: 2.479

  8 in total
  22 in total

1.  Intestinal patches for oral drug delivery.

Authors:  Zancong Shen; Samiir Mitragotri
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

Review 2.  Recent advances in vaccine adjuvants.

Authors:  Manmohan Singh; Derek T O'Hagan
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

Review 3.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.

Authors:  K E Anderson; L A Eliot; B R Stevenson; J A Rogers
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

Review 5.  The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual.

Authors:  A T Florence
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

6.  Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes.

Authors:  Anshuman Shukla; Bhupinder Singh; O P Katare
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 7.  Nanomaterials for cancer therapy and imaging.

Authors:  Ki Hyun Bae; Hyun Jung Chung; Tae Gwan Park
Journal:  Mol Cells       Date:  2011-02-25       Impact factor: 5.034

Review 8.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

9.  M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens.

Authors:  Yok-Teng Chionh; Janet L K Wee; Alison L Every; Garrett Z Ng; Philip Sutton
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

10.  Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries.

Authors:  Imelda Lambkin; Clemencia Pinilla; Christa Hamashin; Lisa Spindler; Shannon Russell; Amy Schink; Rosa Moya-Castro; Gina Allicotti; Lisa Higgins; Melanie Smith; Jackie Dee; Carolyn Wilson; Richard Houghten; Daniel O'Mahony
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.